Overview
Kleiner Perkins is a venture capital firm that provides financial capital and strategic guidance to early-stage startups with high growth potential. It partners with founders across diverse industries to help them move from inception to IPO and beyond. The firm earns returns by taking equity stakes in its portfolio companies and realizing value through exits such as IPOs or acquisitions. Its differentiators include a long history in venture investing, a global and multi-industry portfolio, and a hands-on approach that supports companies from early stages through growth, aligning with ambitious entrepreneurs to transform ideas into scalable businesses.
Work here?Claim your company
Simplify's Take
What believers are saying
- March 2026 fundraise gives Kleiner Perkins dry powder during the AI super-cycle.
- 2026 bets on Mirendil, Profound, K2 Space, and CuspAI show dealflow remains elite.
- SpaceX's June 2026 listing and Figma's July 2025 IPO validate long-horizon venture returns.
What critics are saying
- Five partners after Ev Randle and Annie Case departures strains sourcing and portfolio support.
- Ellen Pao's discrimination case still stains recruiting and founder trust around Kleiner Perkins.
- If AI deal prices compress before exits, the $3.5 billion 2026 funds underperform badly.
What makes Kleiner Perkins unique
- March 24, 2026 KP22 raised $1 billion early-stage capital and $2.5 billion growth capital.
- Kleiner backed Figma, SpaceX, Harvey, and OpenEvidence, proving repeatable top-tier platform access.
- Five-partner team stays concentrated, letting Mamoon Hamid move fast on AI deals.
Help us improve and share your feedback! Did you find this helpful?